首页 | 本学科首页   官方微博 | 高级检索  
     

单克隆抗体MG9用于肺癌的免疫组化研究
引用本文:戴文森 陈菊荣. 单克隆抗体MG9用于肺癌的免疫组化研究[J]. 肿瘤, 1993, 13(3): 128-129,145
作者姓名:戴文森 陈菊荣
作者单位:徐州市第四人民医院病理科(戴文森,陈菊荣,宋永谦),徐州市第四人民医院病理科(党宏)
基金项目:徐州市青年医学科研资助课题
摘    要:
用鼠抗人胃癌单克隆抗体MG_9对147例不同组织学类型的肺癌进行了免疫组织化学研究,探讨MG_9相关抗原在肺癌组织中的表达及其临床意义。结果表明,肺癌MG_9相关抗原表达总阳性率为51.7%(76/147);不同组织学类型肺癌间阳性率差异显著,其中腺癌阳性率92.1%(47/51),显著高于鳞癌的30.2%(13/43)和小细胞癌的30.2%(16/53),P<0.001。这提示:单抗MG_9对肺腺癌有较高特异性,可作为肺腺癌的一种新的标志物。

关 键 词:免疫组织化学 肺肿瘤 单克隆抗体

Immunohistochemical Study of Monoclonal Antibody MG9 in Human Lung Cancer
Dai Wensen,et al.. Immunohistochemical Study of Monoclonal Antibody MG9 in Human Lung Cancer[J]. Tumor, 1993, 13(3): 128-129,145
Authors:Dai Wensen  et al.
Affiliation:Dai Wensen,et al. Dept. of Pathology,4th People's Hospital of XuZhou,XuZhou
Abstract:
The lung cancer(147 cases) were studies using monoclonal antibody MG9 agai-nst gastric carcinoma by Avidin-Biotin peroxidase complex (ABC) method. The resu-Its showed that the total positive rates were 51.7%(76/147). The expression of MG9 related antigen in lung adenocarcinoma were 92.1% (47/51), and 30.2% (13/43) insquamous cell carcinoma and 30.2%(61/53) in small cell cancer. These data suggestthat monoconlal antibody MC9 could be a new tumor marker for adenocarcinomaof the lung.
Keywords:Lung cancer  Monoclonal  Antibody  MG9  Immunohistochemistry
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号